Nisa Investment Advisors
OVID icon

Nisa Investment Advisors’s Ovid Therapeutics OVID Stock Holding History

Nisa Investment Advisors’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.22K Hold
2,351
– – ﹤0.01% 2446
2025
Q4 		$3.83K Hold
2,351
– – ﹤0.01% 2502
2025
Q3 		$3.06K Hold
2,351
– – ﹤0.01% 2534
2025
Q2 		$776 Buy
2,351
+1,951
+488% +$588 ﹤0.01% 2786
2025
Q1 		$125 Sell
400
-1,673
-81% -$1.03K ﹤0.01% 2957
2024
Q4 		$1.94K Buy
2,073
+1,750
+542% +$1.96K ﹤0.01% 2496
2024
Q3 		$381 Buy
323
+180
+126% +$188 ﹤0.01% 2768
2024
Q2 		$110 Buy
+143
New +$398 ﹤0.01% 2872

Other funds holding OVID

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Nisa Investment Advisors's OVID Position: Q1 2026 in Review

Nisa Investment Advisors held its Ovid Therapeutics (OVID) position steady in Q1 2026 at 2,351 shares worth $5.22K. The position accounts for ﹤0.01% of the portfolio, ranked #2446.

Nisa Investment Advisors first reported a position in OVID in Q2 2024 and has held it in 8 quarters since. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

  • Nisa Investment Advisors held 2,351 shares of Ovid Therapeutics worth $5.22K as of Q1 2026.
  • Nisa Investment Advisors left its Ovid Therapeutics share count unchanged in Q1 2026.
  • Ovid Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2446 holding.
  • Nisa Investment Advisors first reported a position in Ovid Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.